[1]胡 岩.蔗糖铁联合重组人促红细胞生成素注射液治疗血液透析患者肾性贫血的疗效[J].医学信息,2021,34(14):157-159.[doi:10.3969/j.issn.1006-1959.2021.14.044]
　HU Yan.Effect of Sucrose Iron Combined with Recombinant Human Erythropoietin Injection on Renal Anemia in Hemodialysis Patients[J].Medical Information,2021,34(14):157-159.[doi:10.3969/j.issn.1006-1959.2021.14.044]
点击复制

蔗糖铁联合重组人促红细胞生成素注射液治疗血液透析患者肾性贫血的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年14期
页码:
157-159
栏目:
药物与临床
出版日期:
2021-07-15

文章信息/Info

Title:
Effect of Sucrose Iron Combined with Recombinant Human Erythropoietin Injection on Renal Anemia in Hemodialysis Patients
文章编号:
1006-1959（2021）14-0157-03
作者:
胡 岩
（辽宁省盘锦市大洼区人民医院血液透析室，辽宁 盘锦 124200）
Author(s):
HU Yan
(Hemodialysis Room,People’s Hospital of Dawa District,Panjin 124200,Liaoning,China)
关键词:
血液透析; 肾性贫血; 重组人促红细胞生成素注射液; 蔗糖铁
Keywords:
Hemodialysis; Renal anemia; Recombinant human erythropoietin injection; Sucrose iron
分类号:
R556
DOI:
10.3969/j.issn.1006-1959.2021.14.044
文献标志码:
A
摘要:
目的 探讨蔗糖铁联合重组人促红细胞生成素注射液治疗血液透析患者肾性贫血的疗效。方法 选取2019年5月~2020年10月我院接受血液透析并存在不同程度肾性贫血患者78例作为研究对象，根据随机双目盲选法分为实验组和常规组，每组39例。常规组给予重组人促红细胞生成素注射液治疗，实验组在常规组用药基础上联合使用蔗糖铁治疗，比较两组临床治疗疗效、贫血指标、铁指标、炎性因子指标及不良反应发生情况。结果 实验组临床治疗总有效率为94.88%，高于常规组的74.36%（P＜0.05）。实验组Hb、RBC、HCT、SF、SI、TSAT高于常规组，TIBC低于常规组（P＜0.05）。两组CRP、IL-6、IL-8水平比较，差异无统计学意义（P＞0.05）。两组不良反应总发生率比较，差异无统计学意义（P＞0.05）。结论 蔗糖铁联合重组人促红细胞生成素注射液治疗血液透析患者肾性贫血的疗效确切，可改善肾性贫血症状，且用药安全性高。
Abstract:
Objective To investigate the efficacy of iron sucrose combined with recombinant human erythropoietin injection in the treatment of renal anemia in hemodialysis patients.Methods From May 2019 to October 2020, 78 patients with renal anemia in our hospital who underwent hemodialysis and had different degrees of renal anemia were selected as the research objects. According to the random binocular blind selection method, they were divided into experimental group and routine group, with 39 cases in each group.The conventional group was treated with recombinant human erythropoietin injection, and the experimental group was treated with iron sucrose on the basis of the conventional group.Comparison of the clinical treatment efficacy, anemia indicators, iron indicators, inflammatory factors and adverse reactions.Results The total effective rate of clinical treatment in the experimental group was 94.88%, which was higher than the 74.36% in the conventional group(P<0.05).The Hb, RBC, HCT, SF, SI, TSAT of the experimental group were higher than those of the conventional group, the TIBC of the experimental group was lower than that of the conventional group(P<0.05).There was no significant difference in the levels of CRP, IL-6, and IL-8 between the two groups (P>0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of iron sucrose and recombinant human erythropoietin injection is effective in treating renal anemia in hemodialysis patients. It can improve the symptoms of renal anemia, and the medication is safe.

参考文献/References:

[1]白荷荷,聂晓静,王园姬.297例重组人促红素及铁剂治疗血液透析肾性贫血的合理性评价[J].药物流行病学杂志,2018,27(6):392-395. [2]吴韵华,陆焕俊,王健生.蔗糖铁联合重组人促红素注射液治疗血液透析患者肾性贫血的疗效观察[J].贵州医药,2018,42(10):1188-1189. [3]Ogoshi Y,Matsui T,Mitani I,et al.Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia[J].ACS Med Chem Lett,2017,8(12):1320-1325. [4]石海燕,蔡婷,赵婷.促红细胞生成素联合左卡尼汀对血液透析肾性贫血患者的临床疗效[J].上海医药,2019,40(19):20-22. [5]赖冬梅,王燕涛.长期血液透析对慢性肾衰竭患者肾性贫血、营养状态及炎症因子水平的影响[J].标记免疫分析与临床,2019,26(7):1150-1154. [6]李梅,黄楠,杨春霞,等.影响长期维持性血液透析患者发生肾性贫血的危险因素分析[J].昆明医科大学学报,2019,40(10):125-130. [7]王靓倩,王静.蔗糖铁联合重组人红细胞生成素对终末期肾病维持性血液透析肾性贫血患者的疗效[J].河南医学研究,2020,29(19):3540-3541. [8]Baradhi KM.An intriguing case of anemia and renal failure[J].Proc (Bayl Univ Med Cent),2019,32(1):78-79. [9]黄碧红,贾守梅,钱璟,等.维持性血液透析患者血氨基末端脑钠肽前体水平与肾性贫血的相关性[J].中华肾脏病杂志,2020,36(5):352-358. [10]潘导,庄文伟,何军,等.重组人促红细胞生成素治疗血液透析患者肾性贫血的临床疗效观察[J].吉林医学,2020,41(1):114-115. [11]张运昊.重组人促红细胞生成素治疗胃肠道恶性肿瘤化疗相关性贫血的疗效观察[J].医学信息,2019,32(8):151-153. [12]Icardi A,Paoletti E,De Nicola L,et al.Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation[J].Nephrol Dial Transplant,2013,28(7):1672-1679. [13]陈丽.重组人促红细胞生成素治疗血液透析患者肾性贫血的临床疗效[J].吉林医学,2018,39(10):1932-1933. [14]廖新媛.蔗糖铁联合促红细胞生成素对维持性血液透析患者肾性贫血的影响[J].泰山医学院学报,2018,39(6):671-673.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Medical Information,2018,31(14):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Medical Information,2018,31(14):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Medical Information,2018,31(14):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[4]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(14):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[5]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Medical Information,2018,31(14):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[6]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Medical Information,2019,32(14):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[7]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Medical Information,2019,32(14):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[8]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Medical Information,2019,32(14):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[9]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Medical Information,2019,32(14):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[10]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
　WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Medical Information,2022,35(14):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
[11]叶益舟,凌铭培,余 娟,等.罗沙司他与促红素在血液透析患者肾性贫血中的效果比较[J].医学信息,2024,37(16):52.[doi:10.3969/j.issn.1006-1959.2024.16.010]
　YE Yi-zhou,LING Ming-pei,YU Juan,et al.Comparison of the Effects of Rosalrestat Erythropoietin on Renal Anemia in Hemodialysis Patients[J].Medical Information,2024,37(14):52.[doi:10.3969/j.issn.1006-1959.2024.16.010]

更新日期/Last Update: 1900-01-01